DOI: 10.1128/CVI.00812-13
Article Information
PubMed
Published By
History
- Received January 6, 2014
- Returned for modification February 14, 2014
- Accepted March 14, 2014
- Published online May 2, 2014.
Copyright & Usage
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- C. J. Papasian, Editor
Article Versions
- Accepted Manuscript version (March 26, 2014).
- You are viewing the most recent version of this article.
Author Information
- Margaret C. Basha,
- Freyja Lynna,
- Brian Moccaa,
- Ray Borrowb,
- Helen Findlowb,
- Musa Hassan-Kingc,
- Marie-Pierre Preziosic,d,
- Olubukola Idokoe,
- Samba Sowf,
- Prasad Kulkarnig and
- F. Marc LaForcec
- aCenter for Biologics Evaluation and Research, FDA, Bethesda, Maryland, USA
- bVaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom
- cMeningitis Vaccine Project, PATH, Ferney-Voltaire, France
- dMeningitis Vaccine Project, Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
- eMedical Research Council, Basse, The Gambia
- fCentre pour le Développement des Vaccins, Bamako, Mali
- gSerum Institute of India, Pune, India
- Address correspondence to Margaret C. Bash, margaret.bash{at}fda.hhs.gov.
Article usage
Development and Use of a Serum Bactericidal Assay Using Pooled Human Complement To Assess Responses to a Meningococcal Group A Conjugate Vaccine in African Toddlers
